Steris PLC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
STERIS plc announces its 2026 Annual General Meeting of Shareholders, detailing proposals for director elections, auditor ratification, and executive compensation.
NYSE
STERIS plc announced the retirement of Dr. Richard M. Steeves from its Board of Directors effective July 31, 2025, and his subsequent withdrawal from re-election at the upcoming Annual General Meeting.
NYSE
STERIS plc has announced its Annual General Meeting for July 31, 2025, where shareholders will vote on the election of directors, auditor appointments, executive compensation, and share issuance authorities.
NYSE
STERIS plc details its agenda for the 2025 Annual General Meeting, including director elections, auditor appointments, and proposals for share issuance authority, alongside reporting robust fiscal 2025 revenue growth and increased net income.
NYSE
STERIS plc is holding its Annual General Meeting on August 1, 2024, and is encouraging shareholders to review proxy materials and vote on key proposals.
NYSE
STERIS plc will hold its Annual General Meeting on August 1, 2024, in Dublin, Ireland, with shareholders voting on director elections, auditor ratification, executive compensation, and share issuance authorizations.